Large-scale technological capabilities with impact on global supply chains for I.V. drugs and #biosimilar therapies: I’ve had great exchange with my team in Graz, Austria during my recent stay. Very impressive to feel their dedication to provide high-quality #healthcare products.

Very impressive. #WeAreFreseniusKabi – the dedication of this team makes a meaningful and decisive difference for patients every day. #CaringForLife is the mission that unites us. To my team around the globe, thank you for your contributions that drive #FreseniusKabi forward.

Insightful exchange about the future of #FreseniusKabi in France with Anne-Marie Descôtes, Ambassador of France to Germany, Dr. Ilde Gorguet, Consulate General France, and Theresa Proyer, Investment Advisor Business France. Looking forward to continuing our historic engagement.

A warm welcome to our new colleagues joining from infusion pioneer Ivenix. Together with you, we are poised to increase market impact in #MedTech and achieve the scale needed to fundamentally change the landscape for infusion therapies, all for the benefit of patients.

The #LEG22 is over. I always value meeting up at the LEG. We’ve had insightful exchange on essential questions such as healthcare of the coming decade. Several colleagues from different departments joined me. Very inspiring and encouraging discussions. #FreseniusKabi

#Healthcare of the future requires a holistic approach. Supply reliability needs progressive industry policy concepts. It was a pleasure to talk about this today with key opinion leaders from politics, economy, science, and media during the #LEG22. #FreseniusKabi

#WorldHealthDay is a strong alert to further increase awareness of challenges in #MedicalAccess around the world. Our efforts strengthen health systems by enabling access to affordable, state-of-the-art #medicines and #technologies in #Biopharma, #Nutrition and #MedTech.

Today’s an exciting day: leadership calls, meetings, Q&A sessions, analyst call, and more. All about two milestone acquisitions. Truly good news for patients, physicians, as well as our company and shareholders. Message by CEO Michael Sen to the global #FreseniusKabi team:

(2/2) We push towards being a key provider of next gen hospital pathways. Industry leadership in #biosimilars will enable us to make a significant difference in #immunology and #oncology. Our strengthened organization is set to push #CaringForLife on an unprecedented scale.

(1/2) A logical step for #FreseniusKabi: we expand MedTech and broaden #Biopharma by acquiring #Ivenix and a majority stake of #mAbxience. Following the investment path defined by #Vision2026, we capitalize on key market and industry trends to capture growth opportunities.

The European Commission approval is the result of our relentless commitment to be an essential force in cancer treatment. Delivers on our #Vision2026, broadening our #biopharmaceutical portfolio. Fresenius Kabi drives the next wave of highly innovative and affordable medicines.

Providing Ukrainian hospitals with medical goods is our contribution to patient treatment. We work closely with humanitarian aid organizations. Our colleagues just packed supply which is on its way now. CEO Michael Sen: “Our efforts to provide assistance will not diminish.”

Great signal for our plans to shape the future of IV therapy. It’s an opportunity for growth in line with Vision 2026: a step towards segment leadership with the ambition to drive best-in-class MedTech. #freseniuskabi https://t.co/4NvW77qjjJ

“The military escalation in Ukraine leaves us all very concerned. We at Fresenius Kabi, are determined and feel obliged to help sustain vital patient care in the country. We have been working intensely to provide essential medicines and blood bags to hospitals.” Michael Sen, CEO.

Last fiscal showcases a job well done by my amazing team at #freseniuskabi. Healthcare’s business and regulatory environment is changing meaningfully, but so are we and we are moving fast. Truly excited to continue our journey to healthcare of the coming decade by Fresenius Kabi.

Congratulations to Dr. Frank-Walter Steinmeier for his successful reelection as German Federal President. I had the honor and privilege to meet and travel with him being part of the business delegation. Highly value his diplomatic skills and ability to unite people.

Being able to deliver lifesaving medicines and technologies requires looking ahead. With Vision 2026, we aim for further industry leadership while also being a good corporate citizen and actively contributing to laid out Sustainable Development Goals of the UN.

World Cancer Day highlights cancer care. Our CEO Michael Sen: “As expert in various oncology-related products, we are committed to offer affordable and high-quality solutions to combat cancer. With Vision 2026, we'll make a difference in the quality of life of ever more people.”

A happy and healthy new year to colleagues and partners in Asia and elsewhere, celebrating Chinese New Year. Adaptive, active, courageous: traits associated to the Year of the Tiger are also cornerstones of our transformation framework Vision 2026.

Greetings to my colleagues in China. Your work is enormously appreciated. Being successful requires looking ahead. Healthcare companies encounter structural and regulatory changes. Vision 2026 is our comprehensive transformation framework to direct our growth and investment path.